Jt Comm J Qual Patient Saf. 2024 Jun;50(6):425-434. doi: 10.1016/j.jcjq.2024.02.005. Epub 2024 Feb 16.
This study evaluated the relationship between Joint Commission accreditation and health care-associated infections (HAIs) in long-term care hospitals (LTCHs).
This observational study used Centers for Medicare & Medicaid Services (CMS) LTCH data for the period 2017 to June 2021. The standardized infection ratio (SIR) of three measures used by the Centers for Disease Control and Prevention's National Healthcare Safety Network were used as dependent variables in a random coefficient Poisson regression model (adjusting for CMS region, owner type, and bed size quartile): catheter-associated urinary tract infections (CAUTIs), Clostridioides difficile infections (CDIs), and central line-associated bloodstream infections (CLABSIs) for the periods 2017 to 2019 and July 1, 2020, to June 30, 2021. Data from January 1 to June 30, 2020, were excluded due to the COVID-19 pandemic.
The data set included 244 (73.3%) Joint Commission-accredited and 89 (26.7%) non-Joint Commission-accredited LTCHs. Compared to non-Joint Commission-accredited LTCHs, accredited LTCHs had significantly better (lower) SIRs for CLABSI and CAUTI measures, although no differences were observed for CDI SIRs. There were no significant differences in year trends for any of the HAI measures. For each year of the study period, a greater proportion of Joint Commission-accredited LTCHs performed significantly better than the national benchmark for all three measures (p = 0.04 for CAUTI, p = 0.02 for CDI, p = 0.01 for CLABSI).
Although this study was not designed to establish causality, positive associations were observed between Joint Commission accreditation and CLABSI and CAUTI measures, and Joint Commission-accredited LTCHs attained more consistent high performance over the four-year study period for all three measures. Influencing factors may include the focus of Joint Commission standards on infection control and prevention (ICP), including the hierarchical approach to selecting ICP-related standards as inputs into LTCH policy.
本研究评估了联合委员会认证与长期护理医院(LTCH)中医疗保健相关感染(HAI)之间的关系。
本观察性研究使用了 2017 年至 2021 年 6 月期间医疗保险和医疗补助服务中心(CMS)的 LTCH 数据。使用疾病控制与预防中心(CDC)国家医疗保健安全网络的三种措施的标准化感染比(SIR)作为因变量,在随机系数泊松回归模型中进行调整(调整 CMS 区域、所有者类型和床位四分位数):导管相关尿路感染(CAUTI)、艰难梭菌感染(CDI)和中心静脉相关血流感染(CLABSI),时间段为 2017 年至 2019 年和 2020 年 7 月 1 日至 2021 年 6 月 30 日。由于 COVID-19 大流行,排除了 2020 年 1 月 1 日至 6 月 30 日的数据。
数据集包括 244 家(73.3%)获得联合委员会认证和 89 家(26.7%)未获得联合委员会认证的 LTCH。与未获得联合委员会认证的 LTCH 相比,认证的 LTCH 在 CLABSI 和 CAUTI 措施方面的 SIR 明显更好(更低),而 CDI SIR 没有差异。任何 HAI 措施的年度趋势均无显着差异。在研究期间的每一年,都有更大比例的获得联合委员会认证的 LTCH 在所有三项措施上的表现均明显优于全国基准(CAUTI 为 p=0.04,CDI 为 p=0.02,CLABSI 为 p=0.01)。
尽管本研究并非旨在确定因果关系,但观察到联合委员会认证与 CLABSI 和 CAUTI 措施之间存在正相关关系,并且在四年的研究期间,获得联合委员会认证的 LTCH 在所有三项措施上的表现都更加一致,达到了较高的水平。影响因素可能包括联合委员会标准对感染控制和预防(ICP)的关注,包括选择与 ICP 相关的标准作为 LTCH 政策输入的分层方法。